The Pathogenesis of OSA in People Living With HIV

University of California, San Diego34 enrolled

Overview

The purpose of this study is to help us understand how HIV and/or Anti-Retroviral Therapy (ART) may predispose individuals to Obstructive Sleep Apnea (OSA). The traditional risk factors for OSA are weight and age. However, people living with HIV on ART seem to have OSA even when they are thin and young. The study involves a detailed physiological sleep study and an MRI of the head and neck to understand the underlying cause of OSA in those with and without HIV.

Participants who have sleep apnea and are using positive airway pressure (PAP) with and without HIV will be enrolled if they otherwise meet all the inclusion criteria, and none of the exclusion criteria. Subjects will undergo two overnight sleep studies (polysomnograms, PSGs) and a MRI scan of the upper airway. The first sleep study will evaluate the severity of sleep disordered breathing and will be identical to a clinical PSG. The second sleep study will measure the physiological traits most important for OSA, such as upper airway anatomy, control of breathing, sleep stability, and upper airway muscle activation. These measurements are performed while subjects sleep using PAP, but the PAP level is adjusted during the night, and the subject's response is measured. The MRI scan will be of the head and neck and will occur during the evening time. Subjects will be encouraged to sleep during this portion of the study, as well.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Obstructive Sleep Apnea HIV/AIDS

Eligibility

Sex: ALLMin age: 40 YearsMax age: 79 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Men and women with physician-diagnosed OSA who have been prescribed CPAP Ages \>= 40 years old * BMI 20 - 35 kg/m2 * For HIV group: physician diagnosis of HIV and viral suppression Exclusion Criteria: * Not compliant with CPAP (by Medicare criteria, e.g. ≥4 hours per night on 70% of nights during a consecutive 30-day period via direct download or visual inspection of usage data). * Use of medication that affects the traits, e.g. narcotics or sedative-hypnotics * Any cardiovascular, pulmonary or renal disease other than well controlled hypertension or asthma. * Pregnancy * Currently smoking * Any respiratory disorder other than OSA or well controlled asthma * contraindication to MRI

Locations (1)

University of California, San Diego

San Diego, California, United States

Outcomes

Primary Outcomes

Upper airway collapsibility (Vpassive)

Upper airway collapsibility, as assessed by rapid withdrawal of PAP

Time frame: Night 2 (Visit 2 - to occur within 6 weeks of enrollment)

Secondary Outcomes

Upper airway muscle responsiveness

As assessed by rapid withdrawal of PAP

Time frame: Night 2 (Visit 2 - to occur within 6 weeks of enrollment)

Pharyngeal fat pad thickness

As measured by MRI of the head and neck

Time frame: MRI study (Visit 3 - to occur within 6 weeks of enrollment)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.